If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Board Appointment

31 Oct 2005 07:00

Torex Retail PLC31 October 2005 31 October 2005 Torex Retail Plc New Board Appointment Torex Retail plc is pleased to announce the appointment of Michael Meade asFinance Director with effect from 1st November. Michael (aged 45) joins from UBS Investment Bank where he was a senior directorin the investment banking division. He has specialised for many years advisingmid-cap and technology companies in the UK and Europe, including advising TorexPLC up until its sale. Michael is a Chartered Accountant with considerableexperience in the City and will add strength to the Board's strategic thinking. Chris Moore, Chairman of Torex Retail said: "We are delighted to have someone of Michael's calibre and experience join ourBoard. His arrival represents a further strengthening of our senior managementteam and follows the recently announced appointment of Phil Cox. Phil hasalready made a significant impact in his primary Treasury role, as well as in abroader operational management perspective. We have known Michael for manyyears as a trusted adviser and know he will make a valuable contribution to theBoard in its next stage of development. He joins us at a time when we areexperiencing a continuation of the very strong organic growth Torex achieved inthe first six months of 2005 trading. The integration of the recently acquiredbusinesses continues to run ahead of plan, both in time and quantum, and insome areas is already fully completed. Commenting on his appointment Michael Meade said: "Torex Retail is an exciting growth company which I am delighted to be joining.I believe that there exists a great opportunity to continue to build a worldbeating force in retail systems and I look forward to helping the Companyachieve its ambitious goals." Richard Thompson, whilst remaining with the Group, will move into a moreoperationally focussed finance role. The Board wishes to thank Richard for hisconsiderable contribution to the Group through the Group's initial phase ofdevelopment since IPO. Enquiries: Torex Retail 01295 753313 Chris Moore, Executive Chairman Citigate Dewe Rogerson 020 7638 9571Ginny Pulbrook/Seb Hoyle/Lucie Holloway Michael Meade owns 10,000 ordinary shares in Torex Retail PLC. There are nofurther details to be disclosed as per Rule 17 of the AIM rules. About Torex Retail plc Torex Retail is a leading independent provider of cutting edge retail technologysolutions to many of the world's principal retailers. Since the company'sflotation in spring 2004 Torex Retail has achieved rapid growth across all ofits markets and has rigorously pursued its goal of becoming the provider ofchoice. As a result, the company now has a presence in all of the major marketsaround the world and has built a strong platform for future growth in line withits strategy. Torex's Retail's product and solution set spans high street andout-of-town retail as well as the petroleum and convenience sector and with over6,000 customer relationships, including Tesco, Woolworth, Selfridges, Shell andArgos, the company has earned a leading reputation amongst retailers. TorexRetail has more than 2800 staff based in 17 countries. www.torexretail.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Mar 20157:09 amRNSDermaPure gains Medicare coverage approval
5th Mar 20151:36 pmRNSIssue of equity and total voting rights
5th Mar 20151:18 pmRNSIssue of equity and total voting rights
5th Mar 201510:38 amRNSUK Patient has world's first OrthoPure XM implant
26th Feb 201510:43 amRNSResignation of Dr Alison Fielding
9th Feb 201512:05 pmRNSResult of General Meeting
4th Feb 201510:59 amRNSIssue of equity and total voting rights
22nd Jan 201511:13 amRNSResults of Placing
22nd Jan 20157:00 amRNSProposed placing of new Ordinary Shares
1st Dec 20149:45 amRNSHolding(s) in Company
28th Nov 20149:45 amRNSHolding(s) in Company
25th Nov 20148:15 amRNSNotice of allowance for US meniscus patent
5th Nov 20147:00 amRNSTissue Regenix gains Medicare and Medicaid Q code
29th Oct 20147:00 amRNSInterim Results
22nd Oct 20149:01 amRNSInterim Results and Capital Markets Day
20th Oct 201410:19 amRNSdCELL(R) presented at prestigious EACTS congress
17th Oct 20143:35 pmRNSInitial Clinical Trial Results
10th Sep 20149:00 amRNSdCELL® technology presented at Royal Society event
30th Jul 20147:00 amRNSUK meniscus clinical trial & DermaPure US updates
25th Jul 20147:00 amRNSTissue Regenix adds European bladder matrix patent
18th Jul 201411:11 amRNSIssue of equity and total voting rights
27th Jun 20143:06 pmRNSResult of AGM
12th Jun 20147:00 amRNSTissue Regenix announces launch of DermaPure in US
22nd May 20147:00 amRNSPreliminary Decision to Approve "Q" Code Request
20th May 20147:00 amRNSDeferred Annual Bonus Award
19th May 201410:21 amRNSAnnual Report & Accounts and Notice of AGM
19th May 20147:00 amRNSPreliminary results for year ended 31 January 2014
16th May 20141:00 pmRNSTissue Regenix adds US patent
12th May 201411:00 amRNSNotice of Preliminary Results
30th Apr 20145:14 pmRNSHolding(s) in Company
28th Apr 20147:00 amRNSTissue Regenix adds Chinese patent
24th Apr 20148:40 amRNSHolding(s) in Company
4th Feb 20143:03 pmRNSIssue of Share Options
31st Jan 20141:11 pmRNSHolding(s) in Company
14th Jan 20145:22 pmRNSIssue of equity and total voting rights
9th Jan 201411:11 amRNSIssue of equity and total voting rights
19th Dec 20137:00 amRNSTissue Regenix to attend JPMorgan Healthcare Event
12th Dec 20137:00 amRNSTissue Regenix signs US distribution agreements
22nd Nov 20137:00 amRNSDirector Share Purchase
29th Oct 20137:00 amRNSPresentation at Proactiveinvestors Forum in Dublin
28th Oct 20134:49 pmRNSDirector Share Purchase
21st Oct 20137:00 amRNSPublication of DermaPure UK trial results
17th Oct 20134:41 pmRNSHolding(s) in Company
17th Oct 20134:41 pmRNSHolding(s) in Company
17th Oct 20134:41 pmRNSHolding(s) in Company
14th Oct 20137:00 amRNSTissue Regenix USA successful technology transfer
8th Oct 20137:00 amRNSInterim Results for six months ended 31 July 2013
12th Aug 20137:00 amRNSTissue Regenix USA Appoints VP of Marketing
6th Aug 20139:41 amRNSHolding(s) in Company
5th Aug 20137:00 amRNSTissue Regenix USA Appoints VP of Operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.